Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26313249 | 0.95 | LMNA (0.32) | POLBTSHRLMNAMAPTHTT | |
| SCHEMBL21999556 | 0.90 | LMNA (0.31) | POLBTSHRLMNAMAPTHTT | |
| SCHEMBL26779319 | 0.90 | PRKDC (0.31) | POLBTSHRLMNAMAPTHTT | |
| SCHEMBL24255857 | 0.89 | ALDH1A1 (0.34) | POLBTSHRLMNAMAPTHTT | |
| SCHEMBL17805989 | 0.89 | CRHR1 (0.31) | TSHRLMNAMAPTKDM4EALDH1A1 | |
| SCHEMBL23154922 | 0.88 | KDM4E (0.31) | POLBKDM4EALDH1A1 | |
| SCHEMBL23154956 | 0.88 | LMNA (0.31) | POLBTSHRLMNAMAPTHTT | |
| SCHEMBL24255709 | 0.88 | MEN1 (0.31) | MAPTKMT2A | |
| SCHEMBL25980126 | 0.88 | PRKDC (0.32) | POLBTSHRLMNAMAPTHTT | |
| SCHEMBL29298734 | 0.88 | KDM4E (0.39) | TSHRMAPTKMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230292599-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO.,LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
| US-20230292599-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO.,LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230292599-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE | CRY1, PPOX, ORC3 | POLB 1189/4885TSHR 4681/4885LMNA 604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.